Nickel JC (2005) Management of urinary tract infections: historical perspective and current strategies: part 1–Before antibiotics. J Urol 173(1):21–26
Colón Pérez J, Villarino Fernández R-A, Domínguez Lago A, Treviño Castellano MM, Pérez del Molino Bernal ML, Sánchez Poza S et al (2024) Addressing sexually transmitted infections due to neisseria gonorrhoeae in the present and future. Microorganisms 12(5):884
Article PubMed PubMed Central Google Scholar
Rajabpour M, Emamie AD, Pourmand MR, Goodarzi NN, Asbagh FA, Whiley DM (2020) Chlamydia trachomatis, neisseria gonorrhoeae, and Trichomonas vaginalis among women with genitourinary infection and pregnancy-related complications in tehran: a cross-sectional study. Int J STD AIDS 31(8):773–780
Nekahiwot S, Debela N (2024) Multi-Drug resistant gonorrhea: an emerging global threat. Int J Infect Dis Therapy 9:17–25
Li Y, Rönn MM, Tuite AR, Chesson HW, Gift TL, Trikalinos TA et al (2022) Estimated costs and quality-adjusted life-years lost due to N. gonorrhoeae infections acquired in 2015 in the united states: a modelling study of overall burden and disparities by age, race/ethnicity, and other factors. Lancet Reg Health Am 16:100364
PubMed PubMed Central Google Scholar
Hassain A, Abdulrahman T, Salman J, Occurrence O (2023) CTX-M I gene in beta lactam resistance neisseria gonorrhoeae isolated form women with endocervical infection e50 occurrence of CTX-M I gene in beta lactam resistance neisseria gonorrhoeae isolated form women with endocervical infection. J Popl Ther Clin Pharmacol 30:49–53
Unemo M, Lahra MM, Escher M, Eremin S, Cole MJ, Galarza P et al (2021) WHO global antimicrobial resistance surveillance for neisseria gonorrhoeae 2017–18: a retrospective observational study. Lancet Microbe 2(11):e627–e36
WHO Bacterial Priority Pathogens List (2024) Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO
Greenberg L (1975) Field trials of a gonococcal vaccine. J Reprod Med 14(1):34–36
Boslego JW, Tramont EC, Chung RC, McChesney DG, Ciak J, Sadoff JC et al (1991) Efficacy trial of a parenteral gonococcal Pilus vaccine in men. Vaccine 9(3):154–162
Wetzler LM, Blake MS, Gotschlich EC (1988) Characterization and specificity of antibodies to protein I of neisseria gonorrhoeae produced by injection with various protein I-adjuvant preparations. J Exp Med 168(5):1883–1897
Russell MW, Jerse AE, Gray-Owen SD (2019) Progress toward a gonococcal vaccine: the way forward. Front Immunol 10:2417
Article PubMed PubMed Central Google Scholar
Gottlieb SL, Ndowa F, Hook EW, Deal C, Bachmann L, Abu-Raddad L et al (2020) Gonococcal vaccines: public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019. Vaccine 38(28):4362–4373
Article PubMed PubMed Central Google Scholar
Szondy I, Lőrincz K, Walter A, Mohammed AA, Hegyi P, Kiss N et al (2025) Evaluating cross-protection: meningococcal vaccines show effectiveness in gonorrhoea prevention—a systematic review and meta-analysis. Vaccine 56:127188
Tzeng YL, Sannigrahi S, Stephens DS (2024) NHBA antibodies elicited by 4CMenB vaccination are key for serum bactericidal activity against neisseria gonorrhoeae. NPJ Vaccines 9(1):223
Article PubMed PubMed Central Google Scholar
Negahdaripour M, Vakili B, Nezafat N (2022) Exosome-based vaccines and their position in next generation vaccines. Int Immunopharmacol 113:109265
Lu Q, Yang H, Peng Y, Dong Z, Nie P, Wang G et al (2024) Intranasal trivalent candidate vaccine induces strong mucosal and systemic immune responses against neisseria gonorrhoeae. Front Immunol 15:1473193
Article PubMed PubMed Central Google Scholar
Lam LN, Sedra A, Kajfasz J, Berges A, Saengpet IS, Adams G et al (2024) Trivalent immunization with metal-binding proteins confers protection against enterococci in a mouse infection model. FEMS Microbes 5:xtae031
Article PubMed PubMed Central Google Scholar
Vemula SV, Sayedahmed EE, Sambhara S, Mittal SK (2017) Vaccine approaches conferring cross-protection against influenza viruses. Expert Rev Vaccines 16(11):1141–1154
Article PubMed PubMed Central Google Scholar
Goh KJ, Stubenrauch CJ, Lithgow T (2024) The TAM, a translocation and assembly module for protein assembly and potential conduit for phospholipid transfer. EMBO Rep 25(4):1711–1720
Article PubMed PubMed Central Google Scholar
Zielke RA, Wierzbicki IH, Baarda BI, Gafken PR, Soge OO, Holmes KK et al (2016) Proteomics-driven antigen discovery for development of vaccines against gonorrhea. Mol Cell Proteom 15(7):2338–2355
Cloud KA, Dillard JP (2004) Mutation of a single lytic transglycosylase causes aberrant septation and inhibits cell separation of neisseria gonorrhoeae. J Bacteriol 186(22):7811–7814
Article PubMed PubMed Central Google Scholar
Chan YA, Hackett KT, Dillard JP (2012) The lytic transglycosylases of neisseria gonorrhoeae. Microb Drug Resist 18(3):271–279
Article PubMed PubMed Central Google Scholar
Granoff DM, Moe GR, Giuliani MM, Adu-Bobie J, Santini L, Brunelli B et al (2001) A novel mimetic antigen eliciting protective antibody to neisseria meningitidis1. J Immunol 167(11):6487–6496
Noori Goodarzi N, Ajdary S, Yekaninejad MS, Fereshteh S, Pourmand MR, Badmasti F (2023) Reverse vaccinology approaches to introduce promising immunogenic and drug targets against antibiotic-resistant neisseria gonorrhoeae: thinking outside the box in current prevention and treatment. Infect Genet Evol 112:105449
Noori Goodarzi N, Barzi SM, Ajdary S, Chiani M, Yekaninejad MS, Badmasti F et al (2025) Immunogenic evaluation of LptD + LtgC as a bivalent vaccine candidate against neisseria gonorrhoeae. J Transl Med 23(1):261
Article PubMed PubMed Central Google Scholar
He W, Shu J, Zhang J, Liu Z, Xu J, Jin X et al (2017) Expression, purification, and renaturation of a recombinant peptide-based HIV vaccine in Escherichia coli. Can J Microbiol 63(6):493–501
Narjes Noori G, Shaghayegh Z, Naghmeh P, Soheila A, Mir Saeed Y, Mohammad P et al (2025) Exploring the prevalence of neisseria gonorrhoeae in women with genitourinary symptoms in Tehran, Iran. Iran J Public Health 54(4):850
Yano J, Fidel PL Jr. (2011) Protocols for vaginal inoculation and sample collection in the experimental mouse model of Candida vaginitis. J Vis Exp 58:338
Rasooli I, Abdolhamidi R, Jahangiri A, Darvish Alipour Astaneh S (2020) Outer membrane protein, Oma87 prevents acinetobacter baumannii infection. Int J Pept Res Ther 26(4):2653–2660
Article PubMed PubMed Central Google Scholar
Semchenko EA, Jen FE, Jennings MP, Seib KL (2022) Assessment of serum bactericidal and opsonophagocytic activity of antibodies to gonococcal vaccine targets. Methods Mol Biol 2414:363–372
Keyhani A, Riazi-Rad F, Pakzad SR, Ajdary S (2014) Human polymorphonuclear leukocytes produce cytokines in response to leishmania major promastigotes. Apmis 122(9):891–897
Song S, Wang S, Jiang X, Yang F, Gao S, Lin X et al (2023) Th1-polarized MtrE-based gonococcal vaccines display prophylactic and therapeutic efficacy. Emerg Microbes Infect 12(2):2249124
Article PubMed PubMed Central Google Scholar
Sikora AE, Gomez C, Le Van A, Baarda BI, Darnell S, Martinez FG et al (2020) A novel gonorrhea vaccine composed of MetQ lipoprotein formulated with CpG shortens experimental murine infection. Vaccine 38(51):8175–8184
Article PubMed PubMed Central Google Scholar
Fiorino F, Pettini E, Pozzi G, Medaglini D, Ciabattini A (2013) Prime-boost strategies in mucosal immunization affect local IgA production and the type of Th response. Front Immunol 4:128
Comments (0)